References
- Centers for Disease Control and Prevention. Increases in drug and opioid overdose deaths—United States, 2000–2014. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6450a3.htm?s_cid=mm6450a3_w. Accessed April 26, 2016.
- Milloy MJ, Wood E, Reading C, Kane D, Montaner J, Kerr T. Elevated overdose mortality rates among First Nations individuals in a Canadian setting: a population-based analysis. Addiction. 2010;105:1962–1970.
- 2011 Annual report on the state of the drugs problem in Europe. European Monitoring Centre for Drugs and Drug Addiction Web site. http://www.emcdda.europa.eu/publications/annual-report/2011. Accessed February 18, 2016.
- Bergenstrom A, Quan VM, Van Nam L, et al. A cross-sectional study on prevalence of non-fatal drug overdose and associated risk characteristics among out-of-treatment injecting drug users in North Vietnam. Subst Use Misuse. 2008;43:73–84.
- Lenton SR, Dietze PM, Degenhardt L, Darke S, Butler TG. Now is the time to take steps to allow peer access to naloxone for heroin overdose in Australia. Drug Alcohol Rev. 2009;28:583–585.
- Buck ML. Naloxone for the reversal of opioid adverse effects. Pediatr Pharmacother. 2002;8(8). http://www.medscape.com/viewarticle/441915. Accessed October 11, 2016.
- Zaller ND, Yokell MA, Green TC, Gaggin J, Case P. The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island. Subst Use Misuse. 2013;48:590–599.
- Barton ED, Ramos J, Colwell C, Benson J, Baily J, Dunn W. Intranasal administration of naloxone by paramedics. Prehosp Emerg Care. 2002;6:54–58.
- Opioid Overdose Prevention Toolkit—Updated 2016. Substance Abuse and Mental Health Services Administration Web site. http://store.samhsa.gov/product/Opioid-Overdose-Prevention-Toolkit-Updated-2016/SMA16-4742. Accessed February 18, 2016.
- Walley AY, Doe-Simkins M, Quinn E, Pierce C, Xuan Z, Ozonoff A. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat. 2013;44:241–247.
- Baca CT, Grant KJ. Take-home naloxone to reduce heroin death. Addiction. 2005;100:1823–1831.
- Doyon S, Aks SE, Schaeffer S. American Academy of Clinical Toxicology, American College of Medical Toxicology, American Association of Poison Control Centers. Expanding access to naloxone in the United States. Clin Toxicol (Phila). 2014;52:989–992.
- Walley AY, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis. BMJ. 2013;346:f174.
- Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158:1–9.
- Naloxone resources. California Society of Addiction Medicine Web site. http://www.csam-asam.org/naloxone-resources. Accessed February 25, 2016.
- Postmarket drug safety information for patients and providers—information about naloxone. Food and Drug Administration Web site. http://www.fda.gov/drugs/drugsafety/postmarketdrugsafetyinformationforpatientsandproviders/ucm472923.htm. Accessed February 25, 2016.
- Naloxone (Lexi-Drugs). Lexicomp Online. http://online.lexi.com/lco/action/doc/retrieve/docid/patch_f/7338. Accessed February 25, 2016.
- Learn about EVZIO® (naloxone HCl injection). Evzio (naloxone HCl injection). http://evzio.com/hcp/about-evzio/what-is-evzio.php. Accessed May 22, 2016.
- Press Announcements. FDA moves quickly to approve easy-to-use nasal spray to treat opioid overdose. Food and Drug Administration Web site. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473505.htm. Accessed February 25, 2016.
- Narcan Nasal Spray. Narcan Nasal Spray Web site. http://www.narcannasalspray.com/. Accessed May 22, 2016.
- Terman G. Naloxone: effects and side effects. Food and Drug Administration Web site. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM300866.pdf. Accessed February 25, 2016.
- Lloyd JM. Cross Discipline Team Leader Review. Food and Drug Administration. http://www.fda.gov/downloads/Drugs/DevelopmentApprovalProcess/DevelopmentResources/UCM480091.pdf. Accessed October 11, 2016.
- Robertson TM, Hendey GW, Stroh G, Shalit M. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose. Prehosp Emerg Care. 2009;13:512–515.
- Barton ED, Colwell CB, Wolfe T, et al. Efficacy of intranasal naloxone as a needleless alternative for treatment of opioid overdose in the prehospital setting. J Emerg Med. 2005;29:265–271.
- Kerr D, Kelly AM, Dietze P, Jolley D, Barger B. Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009;104:2067–2074.
- Loimer N, Hofmann P, Chaudhry HR. Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. Int J Addict. 1994;29:819–827.
- Ashrafioun L, Gamble S, Herrmann M, Baciewicz G. Evaluation of knowledge and confidence following opioid overdose prevention training: a comparison of types of training participants and naloxone administration methods. Subst Abus. 2016;37(1):76–81.
- Maldjian L, Siegler A, Kunins HV. Evaluation of overdose prevention trainings in NYC: knowledge and self-efficacy among participants twelve months after training. Subst Abus. 2016;37(3):459–465.
- Doe-Simkins M, Quinn E, Xuan Z, et al. Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study. BMC Public Health. 2014;14:297.
- Edwards ET, Edwards ES, Davis E, Mulcare M, Wiklund M, Kelley G. Comparative usability study of a novel auto-injector and an intranasal system for naloxone delivery. Pain Ther. 2015;4:89–105.
- Naloxone for Opioid Overdose. FAQs. Pharmacist's Letter Web site. pharmacistsletter.com. http://pharmacistsletter.therapeuticresearch.com/pl/ArticlePDF.aspx?cs=&s=PL&DocumentFileID=206613&DetailID=310702&SegmentID=8611. Accessed February 2016.
- Board of Pharmacy. Naloxone information. http://www.pharmacy.ca.gov/licensing/naloxone_info.shtml. Accessed May 23, 2016.
- Dilokthornsakul P, Moore G, Campbell JD, et al. Risk factors of prescription opioid overdose among colorado medicaid beneficiaries. J Pain. 17(4):436–443.
- Family's ‘full-time job’ is managing son's heroin addiction. NBC News. http://www.nbcnews.com/watch/nightly-news/familys-full-time-job-is-managing-sons-heroin-addiction-222837827940. Accessed February 18, 2016.
- Heroin ODs in overdrive. Chicago Tribune. http://articles.chicagotribune.com/2006-02-06/news/0602060174_1_overdose-drug-users-opiate. Published February 2, 2006. Accessed February 18, 2016.
- Wicked sober fills the gaps to get addicts into drug programs. Boston Magazine. http://www.bostonmagazine.com/news/blog/2014/04/14/wicked-sober-boston-heroin-resources/. Published April 14, 2014. Accessed February 18, 2016.
- Clausen T, Waal H, Thoresen M, Gossop M. Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction. 2009;104:1356–1362.
- Davoli M, Bargagli AM, Perucci CA, et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addiction. 2007;102:1954–1959.
- Oliva E. Saving veterans lives through implementation of Opioid Overdose Education and Naloxone Distribution (OEND). Food and Drug Administration Web site. http://www.fda.gov/downloads/Drugs/NewsEvents/UCM454765.pdf. Published 2015. Accessed October 11, 2016.